Product Description: Indophagolin is a potent, indoline-containing autophagy inhibitor (IC50=140 nM). Indophagolin antagonizes the purinergic receptor P2X4 as well as P2X1 and P2X3 with IC50s of 2.71, 2.40 and 3.49 μM, respectively. Indophagolin also antagonizes the Gq-protein-coupled P2Y4, P2Y6, and P2Y11 receptors (IC50s =3.4~15.4 μM). Indophagolin has a strong antagonistic effect on serotonin receptor 5-HT6 (IC50=1.0 μM) and a moderate effect on receptors 5-HT1B, 5-HT2B, 5-HT4e, and 5-HT7[1].
Applications: COVID-19-immunoregulation
Formula: C19H15BrClF3N2O3S
References: [1]Carnero Corrales MA, et al. Thermal proteome profiling identifies the membrane-bound purinergic receptor P2X4 as a target of the autophagy inhibitor indophagolin [published online ahead of print, 2021 Mar 9]. Cell Chem Biol. 2021;S2451-9456(21)00102-1.
CAS Number: 1207660-00-1
Molecular Weight: 523.75
Compound Purity: 98.05
Research Area: Cancer
Solubility: DMSO : 250 mg/mL (ultrasonic;warming)
Target: 5-HT Receptor;Autophagy;P2X Receptor
English
Deutsch
